Skip to content

Krill Oil and Muscle in Older Adults

Effects of Krill Oil Supplementation on Muscle Function in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04048096
Enrollment
102
Registered
2019-08-07
Start date
2018-03-07
Completion date
2020-03-10
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Sarcopenia

Brief summary

The aim of this study is to determine the effects of krill oil supplementation on muscle mass in function in older adults. Half of the participants will receive krill oil supplements and the other half a placebo.

Interventions

DIETARY_SUPPLEMENTKrill Oil

Aker Biomarine Superba Krill Oil

DIETARY_SUPPLEMENTPlacebo

Mixed vegetable oil

Sponsors

University of Glasgow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* BMI less than 35kg/m2

Exclusion criteria

* Diabetes * severe cardiovascular disease * seizure disorders * uncontrolled hypertension (\>150/90mmHg at baseline measurement) * cancer or cancer that has been in remission \<5 years * ambulatory impairments which would limit ability to perform assessments of muscle function * dementia * taking medication known to affect muscle (e.g. steroids) * have an implanted electronic device (e.g. pacemaker/defibrillator/insulin pump) * on anticoagulant therapy * allergies to seafood * regular consumption of more than 2 portions of oily fish per week.

Design outcomes

Primary

MeasureTime frameDescription
Change in Muscle strengthChange from baseline to 6 monthsknee extensor muscle strength

Secondary

MeasureTime frameDescription
Change in Grip strengthChange from baseline to 6 monthsGrip strength
Change in Blood lipidsChange from baseline to 6 monthsBlood lipids
Change in Muscle thicknessChange from baseline to 6 monthsVastus lateralis muscle thickness
Change in Short performance physical battery testChange from baseline to 6 monthsSPPB
Change in CRPChange from baseline to 6 monthsCRP
Change in Lean MassChange from baseline to 6 monthsMeasured by BIA
Change in Fasting glucoseChange from baseline to 6 monthsFasting glucose
Change in Erythrocyte fatty acid profileChange from baseline to 6 monthsErythrocyte fatty acid profile
Change in Body FatChange from baseline to 6 monthsMeasured by BIA

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026